Cargando…
Influenza vaccination status in multiple sclerosis patients from Latin America
The objective of the present study was to identify the frequency of MS patients in Latin America (LATAM) that received the influenza vaccine during the most recent season and the reasons related to non-vaccination. Cross-sectional study between November and December 2020 in a large cohort of MS pati...
Autores principales: | Rojas, Juan I., Henestroza, Paula, Giachello, Susana, Patrucco, Liliana, Cristiano, Edgardo, Carnero Contentti, Edgar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480125/ https://www.ncbi.nlm.nih.gov/pubmed/34586604 http://dx.doi.org/10.1007/s13365-021-01011-w |
Ejemplares similares
-
Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America
por: ROJAS, Juan Ignacio, et al.
Publicado: (2021) -
Multiple sclerosis epidemiology in Latin America: An updated survey
por: Cristiano, Edgardo, et al.
Publicado: (2017) -
Evaluation of short-term safety of COVID-19 vaccines in patients with
multiple sclerosis from Latin America
por: Alonso, Ricardo, et al.
Publicado: (2021) -
Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review
por: Rojas, Juan I, et al.
Publicado: (2014) -
Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis
por: Carnero Contentti, Edgar, et al.
Publicado: (2022)